![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 405/12 | |
A61K 31/443 | |||
A61P 11/00 |
(11) | Patento numeris | 3339306 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16834669.0 |
Europos patento paraiškos padavimo data | 2016-08-11 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-06-27 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/CN2016/094589 |
Data | 2016-08-11 |
(87) | Numeris | WO 2017/025045 |
Data | 2017-02-16 |
(30) | Numeris | Data | Šalis |
201510489485 | 2015-08-11 | CN |
(72) |
CHEN, Minhua, CN
ZHANG, Yanfeng, CN
LIU, Kai, CN
ZOU, Po, CN
ZHANG, Xiaoyu, CN
|
(73) |
Crystal Pharmatech Co., Ltd.,
B4-101 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
(54) | CRYSTAL FORM OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOLE-5-YL)CYCLOPROPANE FORMAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID AND PREPARATION METHOD THEREOF |
CRYSTAL FORM OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOLE-5-YL)CYCLOPROPANE FORMAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID AND PREPARATION METHOD THEREOF |